Article

Slowing the spread of treatment failure to artemisinin-based combination therapies in Uganda

2025-05-18

Abstract excerpt

<h4>Background</h4> The multiple emergences and continuing spread of partially artemisinin-resistant Plasmodium falciparum in Africa, where about 95% of malaria occurs, is a health challenge that requires urgent attention. The World Health Organization has developed a resistance response strategy that centers on enhancing surveillance, reducing drug pressure, and evaluating novel tools to slow resistance evoluti...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b783452b-9632-58b9-8e64-da3d63cae922
DOI: 10.1101/2025.05.15.25327701

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Slowing the spread of treatment failure to artemisinin-based combination therapies in UgandaDOI 10.1101/2025.05.15.25327701Read

Modeling policy interventions for slowing the spread of artemisinin-resistant pfkelch R561H mutations in Rwanda.Semantic proximity Read

Preventing antimalarial drug resistance with triple artemisinin-based combination therapiesSemantic proximity Read

Changes in susceptibility of Plasmodium falciparum to antimalarial drugs in Uganda over time: 2019-2024.Semantic proximity Read

Treatment Failure in a UK Malaria Patient Harboring Genetically Variant Plasmodium falciparum From Uganda With Reduced In Vitro Susceptibility to Artemisinin and LumefantrineSemantic proximity Read

Efficacy and Safety of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine for The Treatment of Uncomplicated Plasmodium Falciparum Malaria and Prevalence of Molecular Markers Associated With Artemisinin and Partner Drug Resistance in UgandaSemantic proximity Read

Sustained High Prevalence of Multiple Antimalarial Drug Resistance Markers in Uganda in 2023-24Semantic proximity Read

Behavioral factors associated with artemisinin resistance: linking community treatment practices with pfkelch13 mutations in Northern Uganda.Semantic proximity Read

Emerging threat of Partial Artemisinin Resistance Markers in P. falciparum Parasite Populations in multiple geographical locations in high Transmission Regions of UgandaSemantic proximity Read

Sustained high prevalence of multiple antimalarial drug resistance markers in Uganda in 2023-2024.Semantic proximity Read

Changes in susceptibility of <i>Plasmodium falciparum</i> to antimalarial drugs in Uganda over time: 2019-2024Semantic proximity Read

Mapping the prevalence of molecular markers of <i>Plasmodium falciparum</i> artemisinin partial resistance in Africa: a spatial-temporal modelling studySemantic proximity Read

Artemisinin versus nonartemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in Uganda.Semantic proximity Read